Pacira Pharmaceuticals, Inc. v. Research Development Foundation, No. 2:2021cv02241 - Document 107 (D. Nev. 2023)
Court Description: ORDER Granting 98 Motion to Amend Protective Order. Signed by Magistrate Judge Daniel J. Albregts on 3/7/2023. (Copies have been distributed pursuant to the NEF - JQC)
Download PDF
<![CDATA[
Pacira Pharmaceuticals, Inc. v. Research Development Foundation Doc. 107 Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 1 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Karen A. Peterson, Esq., Bar No. 366 ALLISON MacKENZIE, LTD. 402 North Division Street Carson City, NV 89703 Telephone: (775) 687-0202 kpeterson@allisonmackenzie.com Debra L. Spinelli, Esq., Bar No. 9695 PISANELLI BICE PLLC 400 South 7th Street, Suite 300 Las Vegas, NV 89101 Telephone: (702) 214-2100 DLS@pisanellibice.com Daniel S. Leventhal, Esq. (pro hac vice) Jaime Stark, Esq. (pro hac vice) NORTON ROSE FULBRIGHT US LLP 1301 McKenney, Suite 5100 Houston, TX 77010 Telephone: (713) 651-5151 daniel.leventhal@nortonrosefulbright.com jamie.stark@nortonfulbright.com Gregg LoCascio (pro hac vice) Ronald K. Anguas, Jr. (pro hac vice) Justin Bova (pro hac vice) KIRKLAND & ELLIS LLP 1301 Pennsylvania Avenue, N.W. Washington, D.C. 20004 Telephone: (202) 389-5000 gregg.locascio@kirkland.com justin.bova@kirkland.com James S. Renard, Esq. (pro hac vice) Brandy S. Nolan, Esq. (pro hac vice) NORTON ROSE FULBRIGHT US LLP 2200 Ross Avenue, Suite 3600 Dallas, TX 75201 Telephone: (214) 855-8000 james.renard@nortonfulbright.com brandy.nolan@nortonfulbright.com Ryan Kane (pro hac vice) KIRKLAND & ELLIS LLP 601 Lexington Avenue New York, NV 10022 Telephone: (212) 446-4800 ryan.kane@kirkland.com Talbot R. Hansum, Esq. (pro hac vice) Zachary Wegmann, Esq. (pro hac vice) NORTON ROSE FULBRIGHT US LLP 98 San Jacinto Boulevard, Suite 1100 Austin, TX 78701 Telephone: (512) 474-5201 talbot.hansum@nortonfulbright.com zachary.wegmann@nortonfulbright.com Andrew Walter (pro hac vice) KIRKLAND & ELLIS LLP 300 North LaSalle Chicago, IL 60654 Telephone: (312) 862-2000 andrew.walter@kirkland.com Attorneys for Defendant, RESEARCH DEVELOPMENT FOUNDATION Counsel for Plaintiff, PACIRA PHARMACEUTICALS, INC. 19 UNITED STATES DISTRICT COURT DISTRICT OF NEVADA 20 21 22 PACIRA PHARMACEUTICALS, INC., 23 24 25 26 27 Plaintiff, v. RESEARCH DEVELOPMENT FOUNDATION, Case No. 2:21-cv-02241-CDS-DJA JOINT MOTION TO AMEND PROTECTIVE ORDER Defendant. 28 Dockets.Justia.com Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 2 of 6 1 Plaintiff Pacira Pharmaceuticals, Inc. (“Pacira”), and Defendant/Counter-Claimant 2 Research Development Foundation (“RDF”) (collectively, the “Parties”), by and through their 3 respective counsel, and subject to this Court’s approval, submit the following Joint Motion to 4 Amend Protective Order. 5 On May 4, 2022, the Court entered the Parties’ Stipulated Protective Order, ECF No. 42, 6 subject to certain modifications, including provisions governing the procedures for 7 filing documents under seal with this Court. See ECF No. 44. The Court specifically ordered: 8 9 10 11 If the sole ground for a motion to seal is that the opposing party (or non-party) has designated a document as confidential, the designator shall file (within seven days of the filing of the motion to seal) either (1) a declaration establishing sufficient justification for sealing each document at issue or (2) a notice of withdrawal of the designation(s) and consent to unsealing. 12 ECF No. 44 at 3:15-21. The Parties respectfully move the Court to amend this provision of the 13 Protective Order as detailed below. 14 The Parties are currently briefing Pacira’s Motion to Reopen Discovery, ECF No. 91, 15 with briefing scheduled to be completed on March 14, 2023. See L.R. 7-2(b). In addition, the 16 Parties’ dispositive motions are due on March 6, 2023, with briefing scheduled to be completed 17 on April 10, 2023. See id.; ECF No. 90 at 3. The parties anticipate that the forthcoming briefing 18 on these motions will contain material designated as Confidential or Highly Confidential by the 19 opposing party, requiring multiple declarations pursuant to the operative Protective Order. To 20 limit the number of declarations submitted and consolidate the Parties’ justifications for seeking 21 to file materials under seal, the Parties propose adding the following provision to the 22 aforementioned paragraph of the Operative Protective Order: 23 24 25 26 27 28 Notwithstanding the foregoing, if the filing proposed to be sealed is a motion or brief or exhibit thereto, the Parties shall, within fourteen days of completion of briefing on the underlying motion, file a joint submission (1) identifying the information to be sealed, accompanied by sufficient justification for sealing each document at issue, or (2) a notice of withdrawal of the designation(s) and consent to unsealing. The Parties’ will meet and confer in preparing their joint submission. The joint submission will include a proposed public version of the sealed documents redacting only the information that the parties seek to maintain under seal. For the avoidance of doubt, the Parties shall 1 Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 3 of 6 1 file any required submissions relating to briefing on Pacira’s Motion to Reopen Discovery by March 28, 2023, and any required submissions relating to briefing on the Parties’ dispositive motions by April 24, 2023. 2 3 4 5 6 7 8 9 10 11 12 13 This Court has the authority to modify or lift protective orders that it has entered. See Oracle USA, Inc. v. Rimini St., Inc., 2012 WL 6100306, at *10 (D. Nev. Dec. 7, 2012) (citing Empire Blue Cross & Blue Shield v. Janet Greeson's A Place For Us, Inc., 62 F.3d 1217, 1219 (9th Cir.1995)). Here, the Parties’ proposed modification streamlines the sealing process and eliminates the need for the Court to review multiple declarations from each side throughout the pendency of briefing related to Pacira’s Motion to Reopen Discovery and the Parties’ dispositive motions. For the foregoing reasons, the Parties respectfully request the Court to enter the proposed modification to the Protective Order. Respectfully submitted this 6th day of March, 2023. 14 ALLISON MacKENZIE, LTD. 15 16 17 18 19 20 21 22 23 24 25 26 27 By: /s/ Karen A. Peterson KAREN A. PETERSON, ESQ. 402 North Division Street Carson City, NV 89703 DANIEL SCOTT LEVENTHAL, ESQ. JAIME STARK, ESQ. NORTON ROSE FULBRIGHT US LLP 1301 McKinney, Suite 5100 Houston, TX 77010-3095 JAMES S. RENARD, ESQ. BRANDY S. NOLAN, ESQ. NORTON ROSE FULBRIGHT US LLP 2200 Ross Avenue, Suite 3600 Dallas, TX 75201-7932 TALBOT R. HANSUM, ESQ. ZACHARY WEGMANN, ESQ. NORTON ROSE FULBRIGHT US LLP 98 San Jacinto Boulevard, Suite 1100 Austin, TX 78701-4255 Attorneys for Defendant, RESEARCH DEVELOPMENT FOUNDATION 28 2 Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 4 of 6 PISANELLI BICE PLLC 1 2 3 4 5 6 7 8 9 10 11 12 13 By: /s/ Debra L. Spinelli DEBRA L. SPINELLI, ESQ. 400 South 7th Street, Suite 300 Las Vegas, NV 89101 GREGG LOCASCIO, ESQ. RONALD K. ANGUAS, JR., ESQ. JUSTIN BOVA, ESQ. KIRKLAND & ELLIS LLP 1301 Pennsylvania Avenue, N.W. Washington, D.C. 20004 RYAN KANE, ESQ. KIRKLAND & ELLIS LLP 601 Lexington Avenue New York, NY 10022 ANDREW WALTER, ESQ. KIRKLAND & ELLIS LLP 300 North LaSalle Chicago, IL 60654 Attorneys for Plaintiff, PACIRA PHARMACEUTICALS, INC. 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 3 Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 5 of 6 1 PROPOSED ORDER 2 3 4 5 6 7 8 9 10 11 12 13 14 The foregoing proposed modification to the Parties’ Protective Order (ECF No. 44) is GRANTED. IT IS HEREBY ORDERED that the Parties Protective Order, ECF No. 44, at 3:15-21, be amended to state: Notwithstanding the foregoing, if the filing proposed to be sealed is a motion or brief or exhibit thereto, the Parties shall, within fourteen days of completion of briefing on the underlying motion, file a joint submission (1) identifying the information to be sealed, accompanied by sufficient justification for sealing each document at issue, or (2) a notice of withdrawal of the designation(s) and consent to unsealing. The Parties’ will meet and confer in preparing their joint submission. The joint submission will include a proposed public version of the sealed documents redacting only the information that the parties seek to maintain under seal. For the avoidance of doubt, the Parties shall file any required submissions relating to briefing on Pacira’s Motion to Reopen Discovery by March 28, 2023, and any required submissions relating to briefing on the Parties’ dispositive motions by April 24, 2023. IT IS SO ORDERED. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 UNITED MAGISTRATE JUDGE DANIEL STATES J. ALBREGTS UNITED STATES MAGISTRATE JUDGE ____ DATED: ________________________________ DATED: March 7, 2023 CASE NO. 2:21-cv-02241-CDS-DJA Case 2:21-cv-02241-CDS-DJA Document 107 Filed 03/07/23 Page 6 of 6 1 2 CERTIFICATE OF SERVICE 3 I hereby certify that I am an employee of Pisanelli Bice PLLC, and that on this day, I 4 electronically filed the foregoing document with the Clerk of the Court by using the CM/ECF 5 system, and that service will be accomplished on all counsel and persons requesting notice by 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 the Court CM/ECF system, which will send notification of such filing to their email addresses. DATED this 6th day of March, 2023. /s/ Kimberly Peets Kimberly Peets
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
